![When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/01/table1.png)
When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK
![Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer | SpringerLink Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-019-02664-3/MediaObjects/345_2019_2664_Fig5_HTML.png)
Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer | SpringerLink
![Cancers | Free Full-Text | PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer Cancers | Free Full-Text | PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer](https://www.mdpi.com/cancers/cancers-12-00398/article_deploy/html/images/cancers-12-00398-g001.png)
Cancers | Free Full-Text | PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
![Frontiers | Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml Frontiers | Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml](https://www.frontiersin.org/files/Articles/957892/fonc-12-957892-HTML/image_m/fonc-12-957892-t004.jpg)
Frontiers | Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer | PLOS ONE
Efficacy of Androgen Deprivation Therapy for Localized Prostate Cancer: Analysis of pT0 Evaluated by Radical Prostatectomy Speci
![Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708521005811-ga1.jpg)
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect
![MP28-17 THE ADDITION OF BIOMARKERS TO PSA AND MPMRI MAY IMPROVE PROSTATE CANCER DETECTION RATE | Journal of Urology MP28-17 THE ADDITION OF BIOMARKERS TO PSA AND MPMRI MAY IMPROVE PROSTATE CANCER DETECTION RATE | Journal of Urology](https://www.auajournals.org/cms/asset/528fa5b0-5428-4e1f-8c1e-b613e4b62a22/01.ju.0000557533.75965.d3t1.gif)
MP28-17 THE ADDITION OF BIOMARKERS TO PSA AND MPMRI MAY IMPROVE PROSTATE CANCER DETECTION RATE | Journal of Urology
![Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data](https://www.mdpi.com/cancers/cancers-15-00261/article_deploy/html/images/cancers-15-00261-g001.png)